Ernsberger P - Search Results

1

Pharmacological properties of the central antihypertensive agent, moxonidine.

Edwards LP, Brown-Bryan TA, McLean L, Ernsberger P. Edwards LP, et al. Among authors: ernsberger p. Cardiovasc Ther. 2012 Aug;30(4):199-208. doi: 10.1111/j.1755-5922.2011.00268.x. Epub 2011 Apr 5. Cardiovasc Ther. 2012. PMID: 21884003 Free article. Review.

2

The I(1)-imidazoline receptor in PC12 pheochromocytoma cells reverses NGF-induced ERK activation and induces MKP-2 phosphatase.

Edwards L, Ernsberger P. Edwards L, et al. Among authors: ernsberger p. Brain Res. 2003 Aug 1;980(1):71-9. doi: 10.1016/s0006-8993(03)02893-2. Brain Res. 2003. PMID: 12865160

3

Assay of arachidonic acid release coupled to alpha 1- and alpha 2-adrenergic receptors.

Edwards L, Ernsberger P. Edwards L, et al. Among authors: ernsberger p. Methods Mol Biol. 2000;126:375-90. doi: 10.1385/1-59259-684-3:375. Methods Mol Biol. 2000. PMID: 10685424 Review. No abstract available.

4

The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK).

Edwards L, Fishman D, Horowitz P, Bourbon N, Kester M, Ernsberger P. Edwards L, et al. Among authors: ernsberger p. J Neurochem. 2001 Dec;79(5):931-40. doi: 10.1046/j.1471-4159.2001.00632.x. J Neurochem. 2001. PMID: 11739604 Free article.

5

Pharmacology of moxonidine: an I1-imidazoline receptor agonist.

Ernsberger P. Ernsberger P. J Cardiovasc Pharmacol. 2000;35(7 Suppl 4):S27-41. doi: 10.1097/00005344-200000004-00005. J Cardiovasc Pharmacol. 2000. PMID: 11346217 Review.

6

Contrasting metabolic effects of antihypertensive agents.

Velliquette RA, Ernsberger P. Velliquette RA, et al. Among authors: ernsberger p. J Pharmacol Exp Ther. 2003 Dec;307(3):1104-11. doi: 10.1124/jpet.103.054221. Epub 2003 Oct 13. J Pharmacol Exp Ther. 2003. PMID: 14557373

7

Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.

Ernsberger P, Koletsky RJ, Collins LA, Bedol D. Ernsberger P, et al. Cardiovasc Drugs Ther. 1996 Jun;10 Suppl 1:275-82. doi: 10.1007/BF00120497. Cardiovasc Drugs Ther. 1996. PMID: 8827950

8

Pharmacology of moxonidine, an I1-imidazoline receptor agonist.

Ziegler D, Haxhiu MA, Kaan EC, Papp JG, Ernsberger P. Ziegler D, et al. Among authors: ernsberger p. J Cardiovasc Pharmacol. 1996;27 Suppl 3:S26-37. doi: 10.1097/00005344-199627003-00005. J Cardiovasc Pharmacol. 1996. PMID: 8872297 Review.

9

Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).

Ernsberger P, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, Friedman JE. Ernsberger P, et al. J Pharmacol Exp Ther. 1999 Jan;288(1):139-47. J Pharmacol Exp Ther. 1999. PMID: 9862764

10

Cardiac effects of moxonidine in spontaneously hypertensive obese rats.

Mukaddam-Daher S, Menaouar A, El-Ayoubi R, Gutkowska J, Jankowski M, Velliquette RA, Ernsberger P. Mukaddam-Daher S, et al. Among authors: ernsberger p. Ann N Y Acad Sci. 2003 Dec;1009:244-50. doi: 10.1196/annals.1304.030. Ann N Y Acad Sci. 2003. PMID: 15028594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page